CDK9-IN-25

• Target :

  SARS-CoV|||Virus Protease|||CDK

• Related Pathways :

  Microbiology/Virology|||Cell Cycle/Checkpoint

• Bioactivity :

  CDK9-IN-25 (compound 4a), an imidazopyrazine derivative, functions as a CDK9 inhibitor with an IC50 of 0.24 ?M. It also exhibits affinity for the main protease of COVID-19 and demonstrates antiviral activity against human coronavirus 229E, with an IC50 of 63.28 ?M [1].

• Molecular Formula :

  C15H16FN5

• Molecular Weight :

  285.32

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C